Trimester-specific reference intervals for haemoglobin A1c (HbA1c) in pregnancy

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 5, 2012, Pages 905-909

  O'Connor, Catherine ^a   O'Shea, Paula Mary ^b   Owens, Lisa Ann ^a   Carmody, Louise ^a   Avalos, Gloria ^a   Nestor, Laura ^a   Lydon, Katherine ^a   Dunne, Fidelma ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Glycated haemoglobin (HbA1c); Pregnancy; Reference intervals; Trimester

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; REFERENCE VALUE; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; BLOOD CHEMICAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTERS; REFERENCE VALUES; YOUNG ADULT;

EID: 84867776041     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.397     Document Type: Article

References (28)

1. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
2. Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard JG, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009;32:1046-8.
3. Dunne FP, Avalos G, Durkan M, Mitchell Y, Gallacher T, Keenan M, et al. Atlantic DIP: pregnancy outcome for women with prege-stational diabetes along the Irish Atlantic seaboard. Diabetes Care 2009;32:1205-6.
4. Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. The role of modifiable pre-pregnancy risk factors in preventing adverse fetal outcomes among women with type 1 and type 2 diabetes. Acta Obstet Gynecol Scand 2009;88:1153-7.
5. Jones G, Barker A. Reference intervals. Clin Biochem Rev 2008;29(Suppl 1):S93-7.
6. Nielsen LR, Ekbom P, Damm P, Glumer C, Frandsen MM, Jensen DM, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004;27:1200-1.
7. Mosca A, Paleari R, Dalfra MG, Di Cianni G, Cuccuru I, Pellegrini G, et al. Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 2006;52:1138-43.
8. Radder JK, Van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med 2005;63:256-9.
9. O'Kane MJ, Lynch PL, Moles KW, Magee SE. Determination of a diabetes control and complications trial-aligned HbA (1c) reference range in pregnancy. Clin Chim Acta 2001;311:157-9.
10. Mills JL, Jovanovic L, Knopp R, Aarons J, Conley M, Park E, et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study. Metabolism 1998;47:1140-4.
11. Cousins L, Rigg L, Hollingsworth D, Brink G, Aurand J, Yen SS. The 24-hour excursion and diurnal rhythm of glucose, insulin, and c-peptide in normal pregnancy. Am J Obstet Gynecol 1980;136:483-8.
12. Lind T, Cheyne GA. Effect of normal pregnancy upon the glyco-sylated haemoglobins. Br J Obstet Gynaecol 1979;86:210-3.
13. Lurie S. Age distribution of erythrocyte population in late pregnancy. Gynecol Obstet Invest 1990;30:147-9.
14. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002;40:78-89.
15. Hanas R, John G. 2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Clin Chem 2010;56:1362-4.
16. Geistanger A, Arends S, Berding C, Hoshino T, Jeppsson JO, Little R, et al. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden. Clin Chem 2008;54:1379-85.
17. The Health Service Executive (HSE) Guidelines for the management of pre-gestational and gestational diabetes mellitus from pre-conception to the postnatal period, 1st ed. Dublin: Health Service Executive, 2010.
18. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009;114:1326-31.
19. Weykamp CW, Mosca A, Gillery P, Panteghini M. The analytical goals for hemoglobin A1c measurement in IFCC units and National Glycohemoglobin Standardization Program units are different. Clin Chem 2011;57:1204-6.
20. Burtis CA, Ashwood ER, Bruns DF. Tietz textbook of clinical chemistry and molecular diagnostics, 4th ed. St. Louis Missouri: Elsevier Saunders, 2006.
21. Harris N, Kunicka J, Kratz A. The Advia 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory. Lab Hematol 2005;11:47-61.
22. Dixon W. Processing data for outliers. Biometrics 1953;9:74-89.
23. Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971;17:275-84.
24. Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved Guideline-CLSI document C28-A3, 3rd ed. Wayne, Pennsylvania: CLSI, 2008.
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
26. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
27. Peterson CM, Jovanovic L, Raskin P, Goldstein DE. A comparative evaluation of glycosylated haemoglobin assays: feasibility of references and standards. Diabetologia 1984;26:214-7.
28. John WG, Mosca A, Weykamp C, Goodall I. HbA1c standardisation: history, science and politics. Clin Biochem Rev 2007;28:163-8.